Page 112 - Read Online

Page 12 of 12 Jones et al. Microbiome Res Rep 2024;3:24 https://dx.doi.org/10.20517/mrr.2023.78

56. Wirawan RE, Klesse NA, Jack RW, Tagg JR. Molecular and genetic characterization of a novel nisin variant produced by
Streptococcus uberis. Appl Environ Microbiol 2006;72:1148-56. DOI PubMed PMC
57. Marković KG, Grujović MŽ, Koraćević MG, et al. Colicins and microcins produced by Enterobacteriaceae: characterization, mode of
action, and putative applications. Int J Environ Res Public Health 2022;19:11825. DOI PubMed PMC
58. Hahn-Löbmann S, Stephan A, Schulz S, et al. Colicins and salmocins - new classes of plant-made non-antibiotic food antibacterials.
Front Plant Sci 2019;10:437. DOI PubMed PMC
59. Hussein AR, Khalaf ZZ, Kadhim MJ. The antibiofilm activity of bacteriocin produced by Proteus mirabilis against some bacterial
species. Curr Res Microbiol Biotechnol 2017;5:1071-7. Available from: https://www.researchgate.net/profile/Alyaa-Hussein-2/
publication/328052134_The_antibiofilm_activity_of_bacteriocin_produced_by_Proteus_mirabilis_against_some_bacterial_species/
links/5bb5208ca6fdccd3cb8517fd/The-antibiofilm-activity-of-bacteriocin-produced-by-Proteus-mirabilis-against-some-bacterial-
species.pdf. [Last accessed on 26 Mar 2024]
60. Roy SM, Riley MA. Evaluation of the potential of colicins to prevent extraluminal contamination of urinary catheters by Escherichia
coli. Int J Antimicrob Agents 2019;54:619-25. DOI PubMed
61. Sharp C, Boinett C, Cain A, et al. O-antigen-dependent colicin insensitivity of uropathogenic Escherichia coli. J Bacteriol
2019;201:e00545-18. DOI PubMed PMC
62. Sharma D, Gajjar D, Seshadri S. Understanding the role of gut microfloral bifidobacterium in cancer and its potential therapeutic
applications. Microbiome Res Rep 2024;3:3. DOI PubMed PMC
63. Sassone-Corsi M, Nuccio SP, Liu H, et al. Microcins mediate competition among Enterobacteriaceae in the inflamed gut. Nature
2016;540:280-3. DOI PubMed PMC
64. Culligan EP, Hill C, Sleator RD. Probiotics and gastrointestinal disease: successes, problems and future prospects. Gut Pathog
2009;1:19. DOI PubMed PMC
65. Ellis JC, Ross RP, Hill C. Nisin Z and lacticin 3147 improve efficacy of antibiotics against clinically significant bacteria. Future
Microbiol 2019;14:1573-87. DOI PubMed